Exact Mass: 574.3141666

Exact Mass Matches: 574.3141666

Found 500 metabolites which its exact mass value is equals to given mass value 574.3141666, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

CucurbitacinA

[(E,5R)-5-[(2S,8S,9R,10R,13R,14S,16R,17R)-2,16-dihydroxy-9-(hydroxymethyl)-4,4,13,14-tetramethyl-3,11-dioxo-2,7,8,10,12,15,16,17-octahydro-1H-cyclopenta[a]phenanthren-17-yl]-5-hydroxy-1,1-dimethyl-4-oxo-hex-2-enyl] acetate

C32H46O9 (574.3141666)

Cucurbitacin A is a cucurbitacin. Cucurbitacin A is a natural product found in Hintonia standleyana, Cucumis prophetarum, and other organisms with data available.

Asclepin

3-O-Acetylcalotropin

C31H42O10 (574.2777832)

D020011 - Protective Agents > D002316 - Cardiotonic Agents > D002301 - Cardiac Glycosides

Herbimycin

herbimycin a

C30H42N2O9 (574.2890162)

A 19-membered macrocyle incorporating a benzoquinone ring and a lactam functionality. It is an ansamycin antibiotic that induces apoptosis and displays antitumour effects. C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C259 - Antineoplastic Antibiotic D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D012294 - Rifamycins D000970 - Antineoplastic Agents D004791 - Enzyme Inhibitors

Ganoderic acid K

6-[16-(acetyloxy)-5,9-dihydroxy-2,6,6,11,15-pentamethyl-12,17-dioxotetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadec-1(10)-en-14-yl]-2-methyl-4-oxoheptanoic acid

C32H46O9 (574.3141666)

Ganoderic acid K is found in mushrooms. Ganoderic acid K is a constituent of Ganoderma lucidum (reishi) Constituent of Ganoderma lucidum (reishi). Ganoderic acid K is found in mushrooms.

Ganoderic acid alpha

6-[16-(acetyloxy)-5,12-dihydroxy-2,6,6,11,15-pentamethyl-9,17-dioxotetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadec-1(10)-en-14-yl]-2-methyl-4-oxoheptanoic acid

C32H46O9 (574.3141666)

Ganoderic acid alpha is found in mushrooms. Ganoderic acid alpha is a constituent of Ganoderma lucidum (reishi). Constituent of Ganoderma lucidum (reishi). Ganoderic acid alpha is found in mushrooms.

Cyclo(Arg-Gly-Asp-D-Phe-Val)

2-(5-benzyl-11-{3-[(diaminomethylidene)amino]propyl}-3,6,9,12,15-pentaoxo-8-(propan-2-yl)-1,4,7,10,13-pentaazacyclopentadecan-2-yl)acetic acid

C26H38N8O7 (574.2863318)

herbimycin a

({8,13,14,17-tetramethoxy-4,10,12,16-tetramethyl-3,20,22-trioxo-2-azabicyclo[16.3.1]docosa-1(21),4,6,10,18-pentaen-9-yl}oxy)methanimidate

C30H42N2O9 (574.2890162)

3-{1-[6,7-Diethoxy-2-(morpholin-4-yl)quinazolin-4-yl]piperidin-4-yl}-1,6-dimethyl-1,2,3,4-tetrahydroquinazoline-2,4-dione

C31H38N6O5 (574.2903537999999)

PA(8:0/18:2(10E,12Z)+=O(9))

[(2R)-3-(octanoyloxy)-2-{[(10E,12Z)-9-oxooctadeca-10,12-dienoyl]oxy}propoxy]phosphonic acid

C29H51O9P (574.3270526)

PA(8:0/18:2(10E,12Z)+=O(9)) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(8:0/18:2(10E,12Z)+=O(9)), in particular, consists of one chain of one octanoyl at the C-1 position and one chain of 9-oxo-octadecadienoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

PA(18:2(10E,12Z)+=O(9)/8:0)

[(2R)-2-(octanoyloxy)-3-{[(10E,12Z)-9-oxooctadeca-10,12-dienoyl]oxy}propoxy]phosphonic acid

C29H51O9P (574.3270526)

PA(18:2(10E,12Z)+=O(9)/8:0) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(18:2(10E,12Z)+=O(9)/8:0), in particular, consists of one chain of one 9-oxo-octadecadienoyl at the C-1 position and one chain of octanoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

PA(8:0/18:2(9Z,11E)+=O(13))

[(2R)-3-(octanoyloxy)-2-{[(9Z,11E)-13-oxooctadeca-9,11-dienoyl]oxy}propoxy]phosphonic acid

C29H51O9P (574.3270526)

PA(8:0/18:2(9Z,11E)+=O(13)) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(8:0/18:2(9Z,11E)+=O(13)), in particular, consists of one chain of one octanoyl at the C-1 position and one chain of 13-oxo-octadecadienoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

PA(18:2(9Z,11E)+=O(13)/8:0)

[(2R)-2-(octanoyloxy)-3-{[(9Z,11E)-13-oxooctadeca-9,11-dienoyl]oxy}propoxy]phosphonic acid

C29H51O9P (574.3270526)

PA(18:2(9Z,11E)+=O(13)/8:0) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(18:2(9Z,11E)+=O(13)/8:0), in particular, consists of one chain of one 13-oxo-octadecadienoyl at the C-1 position and one chain of octanoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

PA(8:0/18:3(10,12,15)-OH(9))

[(2R)-2-{[(10E,12E,15E)-9-hydroxyoctadeca-10,12,15-trienoyl]oxy}-3-(octanoyloxy)propoxy]phosphonic acid

C29H51O9P (574.3270526)

PA(8:0/18:3(10,12,15)-OH(9)) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(8:0/18:3(10,12,15)-OH(9)), in particular, consists of one chain of one octanoyl at the C-1 position and one chain of 9-hydroxyoctadecatrienoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

PA(18:3(10,12,15)-OH(9)/8:0)

[(2R)-3-{[(10E,12E,15E)-9-hydroxyoctadeca-10,12,15-trienoyl]oxy}-2-(octanoyloxy)propoxy]phosphonic acid

C29H51O9P (574.3270526)

PA(18:3(10,12,15)-OH(9)/8:0) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(18:3(10,12,15)-OH(9)/8:0), in particular, consists of one chain of one 9-hydroxyoctadecatrienoyl at the C-1 position and one chain of octanoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

PA(8:0/18:3(9,11,15)-OH(13))

[(2R)-2-{[(9E,11E,15E)-13-hydroxyoctadeca-9,11,15-trienoyl]oxy}-3-(octanoyloxy)propoxy]phosphonic acid

C29H51O9P (574.3270526)

PA(8:0/18:3(9,11,15)-OH(13)) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(8:0/18:3(9,11,15)-OH(13)), in particular, consists of one chain of one octanoyl at the C-1 position and one chain of 13-hydroxyoctadecatrienoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

PA(18:3(9,11,15)-OH(13)/8:0)

[(2R)-3-{[(9E,11E,15E)-13-hydroxyoctadeca-9,11,15-trienoyl]oxy}-2-(octanoyloxy)propoxy]phosphonic acid

C29H51O9P (574.3270526)

PA(18:3(9,11,15)-OH(13)/8:0) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(18:3(9,11,15)-OH(13)/8:0), in particular, consists of one chain of one 13-hydroxyoctadecatrienoyl at the C-1 position and one chain of octanoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

Cucurbitacin A

[(E)-6-[2,16-dihydroxy-9-(hydroxymethyl)-4,4,13,14-tetramethyl-3,11-dioxo-2,7,8,10,12,15,16,17-octahydro-1H-cyclopenta[a]phenanthren-17-yl]-6-hydroxy-2-methyl-5-oxohept-3-en-2-yl] acetate

C32H46O9 (574.3141666)

Cucurbitacin a is a member of the class of compounds known as cucurbitacins. Cucurbitacins are polycyclic compounds containing the tetracyclic cucurbitane nucleus skeleton, 19-(10->9b)-abeo-10alanost-5-ene (also known as 9b-methyl-19-nor lanosta-5-ene), with a variety of oxygenation functionalities at different positions. Cucurbitacin a is practically insoluble (in water) and a very weakly acidic compound (based on its pKa). Cucurbitacin a can be found in cucumber, which makes cucurbitacin a a potential biomarker for the consumption of this food product.

A steroid lactone isolated from Elaeodendron tangenala and Elaeodendron glaucum and exhibits antiproliferative activity against A2780 human ovarian cancer cells.

2-O-Acetylcerleaside A

C32H46O9 (574.3141666)

Meliavolkinin

C35H42O7 (574.2930382)

Cephalosporin P1

C33H50O8 (574.35055)

Galphimine I

C32H46O9 (574.3141666)

Galphimine E

C32H46O9 (574.3141666)

Papulacandin D

C31H42O10 (574.2777832)

A papulacandin that is papulacandin A in which the 6-O-acylgalactosyl group is replaced by a hydrogen. It is a carbohydrate-containing antibiotic from the deuteromycetous fungus Papularia sphaerosperma which shows potent antifungal activity against Candida albicans. D000890 - Anti-Infective Agents > D000935 - Antifungal Agents > D054714 - Echinocandins

Tricalysioside O

C28H46O12 (574.2989116)

13beta,29-Dihydroxymilbemycin A4

C32H46O9 (574.3141666)

turrapubesic acid C

C31H42O10 (574.2777832)

Cucurbitacin

C33H50O8 (574.35055)

2-methylbutanoic acid (3R,5R,5aS,6S,9S,9aS,10R)-10-(acetyloxy)-5a-[(acetyloxy)methyl]-5-(benzoyloxy)-octahydro-9-hydroxy-2,2,9-trimethyl-2H-3,9a-methano-1-benzoexepin-6-yl ester|6alpha,13-bis(acetyloxy)-9beta-(benzoyloxy)-4alpha-hydroxy-1beta-[(2-methylbutanoyl)oxy]-beta-dihydroagarofuran

2-methylbutanoic acid (3R,5R,5aS,6S,9S,9aS,10R)-10-(acetyloxy)-5a-[(acetyloxy)methyl]-5-(benzoyloxy)-octahydro-9-hydroxy-2,2,9-trimethyl-2H-3,9a-methano-1-benzoexepin-6-yl ester|6alpha,13-bis(acetyloxy)-9beta-(benzoyloxy)-4alpha-hydroxy-1beta-[(2-methylbutanoyl)oxy]-beta-dihydroagarofuran

C31H42O10 (574.2777832)

ingol-3,8,12-triacetate-7-tiglate

C31H42O10 (574.2777832)

wuweizidilactone C

C31H42O10 (574.2777832)

Spirostan-2,3,27-triol, triacetate, (2.alpha.,3.beta.,5.alpha.,25S)-

C33H50O8 (574.35055)

DTXSID90907998

C31H42O10 (574.2777832)

dichrostachine P

C35H42O7 (574.2930382)

Piscidinol D

C32H46O9 (574.3141666)

Isocephalosporin P(1)

C33H50O8 (574.35055)

30-hydroxy petuniasterone A

C32H46O7S (574.2964086)

Anhydrodebromoaplysiatoxin

C32H46O9 (574.3141666)

3-epi-Sceptrumgenin-3-beta-D-glucopyranosid

C33H50O8 (574.35055)

1-benzoyl-2-methoxy-8,8-dimethyl-4,5-bis(3-methylbut-2-enyl)-7-[(3-methyl-4-acetoxy-but-2-enyl)]endo-bicyclo[3.3.1]non-2-ene-4,9-dione

C36H46O6 (574.3294215999999)

Thesine

C34H42N2O6 (574.3042712)

Brasiliensophyllic acid C

C36H46O6 (574.3294215999999)

3beta-O-(2-O-acetyl-alpha-L-thevetosyl)-14beta-hydroxy-7-en-5beta-card-20(22)-enolide|3??-O-(2-O-Acetyl-??-L-thevetosyl)-14??-hydroxy-7-en-5??-card-20(22)-enolide|7,8-dehydrocerberin

C32H46O9 (574.3141666)

Tyledoside G

C31H42O10 (574.2777832)

Phytolaccagenin A

C33H50O8 (574.35055)

15alpha-hydroxy-16-dehydroxy-16(24)-en-foetidinol-3-O-beta-D-xylopyranoside

C32H46O9 (574.3141666)

C34H42N2O6

C34H42N2O6 (574.3042712)

Cotyledoside

C31H42O10 (574.2777832)

microginin 91-A

C28H51ClN4O6 (574.3496936)

citreohybridone L

C31H42O10 (574.2777832)

17beta-hydroxypetuniasterone A

C32H46O7S (574.2964086)

7beta-hydroxycucurbitacin B

C32H46O9 (574.3141666)

(1S,4S,5S,6R,7R,8R,9S,10S)1,6,8,15-tetra-acetoxy-9-benzoyloxy-4-hydroxy-dihydro-beta-agarofuran

C31H42O10 (574.2777832)

6-O-[(7Z,10Z,13Z)-hexadeca-7,10,13-trienoyl]-beta-D-fructofuranosyl-(2->1)-alpha-D-glucopyranoside

C28H46O12 (574.2989116)

brujavanone D

C33H50O8 (574.35055)

Plocigenin

C35H42O7 (574.2930382)

butyl lucidenate P

C33H50O8 (574.35055)

Teraspiridole B_130089

C34H42N2O6 (574.3042712)

12-O-decanoyl-7-oxo-5-ene-phorbol-13-acetate|12-O-neodecanoyl-7-oxo-5-enephorbol-13-acetate|daphwanin

C32H46O9 (574.3141666)

C31H42O10

C31H42O10 (574.2777832)

wuweizidilactone F

C31H42O10 (574.2777832)

C32H46O9

C32H46O9 (574.3141666)

Physachenolide C

C31H42O10 (574.2777832)

13-acetyltrichoverrin B

C31H42O10 (574.2777832)

7,9,10-trideacetylabeobaccatin VI

C31H42O10 (574.2777832)

3beta-O-(2-O-acetyl-alpha-L-acofriosyl)-16-anhydrogitoxigenin|vallarisoside

C32H46O9 (574.3141666)

Affinosid B

C31H42O10 (574.2777832)

milbemycin beta10

C33H50O8 (574.35055)

3,7,12-O-triacetyl-8-O-tigloylingol

C31H42O10 (574.2777832)

Turbicoryn

C29H50O11 (574.335295)

C30H42N2O9

C30H42N2O9 (574.2890162)

Euphohelin B

C31H42O10 (574.2777832)

inocalophyllin A methyl ester

C36H46O6 (574.3294215999999)

Asclepin (3-O-Acetyl-caltropin)|Asclepin (3-O-acetylcaltropin)

C31H42O10 (574.2777832)

Ile Ile Arg Ser Ser

C24H46N8O8 (574.3438436)

Glu Asp Arg Arg

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-carboxybutanamido]-3-carboxypropanamido]-5-carbamimidamidopentanamido]-5-carbamimidamidopentanoic acid

C21H38N10O9 (574.2823098)

Met Leu Arg Ala Ala

C24H46N8O6S (574.3260855999999)

Asp Lys Leu Gly Glu

C24H42N6O10 (574.2962272)

Val Leu Lys Asp Ser

C25H46N6O9 (574.3326106)

Asp Gln Val Leu Ser

C24H42N6O10 (574.2962272)

Thr Pro Thr Glu Lys

C24H42N6O10 (574.2962272)

Arg Glu Asp Arg

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-4-carboxybutanamido]-3-carboxypropanamido]-5-carbamimidamidopentanoic acid

C21H38N10O9 (574.2823098)

Tyr His Leu Glu

C27H38N6O8 (574.2750988)

Lys Leu Glu Ala Thr

C25H46N6O9 (574.3326106)

Lys Asn Asn Thr Val

C23H42N8O9 (574.3074602)

Glu Arg Ile Ala Ser

C23H42N8O9 (574.3074602)

Glu Glu Val Lys Ala

C24H42N6O10 (574.2962272)

Ganoderic acid alpha

6-[16-(acetyloxy)-5,12-dihydroxy-2,6,6,11,15-pentamethyl-9,17-dioxotetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-1(10)-en-14-yl]-2-methyl-4-oxoheptanoic acid

C32H46O9 (574.3141666)

Ganoderic Acid K

6-[16-(acetyloxy)-5,9-dihydroxy-2,6,6,11,15-pentamethyl-12,17-dioxotetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-1(10)-en-14-yl]-2-methyl-4-oxoheptanoic acid

C32H46O9 (574.3141666)

C31H42O10_7aH,13aH-Cyclopenta[7,8]phenanthro[2,3-b]pyrano[3,2-e][1,4]dioxin-13a-carboxaldehyde, 11-(acetyloxy)-1-(2,5-dihydro-5-oxo-3-furanyl)eicosahydro-3a,11a-dihydroxy-9,15a-dimethyl-, (1R,3aS,3bR,6aR,7aS,9R,11S,11aS,12aR,13aR,15aR)

NCGC00385378-01_C31H42O10_7aH,13aH-Cyclopenta[7,8]phenanthro[2,3-b]pyrano[3,2-e][1,4]dioxin-13a-carboxaldehyde, 11-(acetyloxy)-1-(2,5-dihydro-5-oxo-3-furanyl)eicosahydro-3a,11a-dihydroxy-9,15a-dimethyl-, (1R,3aS,3bR,6aR,7aS,9R,11S,11aS,12aR,13aR,15aR)-

C31H42O10 (574.2777832)

Ala Ile Trp Trp

(2S)-2-[(2S)-2-[(2S,3S)-2-[(2S)-2-aminopropanamido]-3-methylpentanamido]-3-(1H-indol-3-yl)propanamido]-3-(1H-indol-3-yl)propanoic acid

C31H38N6O5 (574.2903537999999)

Ala Leu Trp Trp

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-4-methylpentanamido]-3-(1H-indol-3-yl)propanamido]-3-(1H-indol-3-yl)propanoic acid

C31H38N6O5 (574.2903537999999)

Ala Trp Ile Trp

(2S)-2-[(2S,3S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-3-(1H-indol-3-yl)propanamido]-3-methylpentanamido]-3-(1H-indol-3-yl)propanoic acid

C31H38N6O5 (574.2903537999999)

Ala Trp Leu Trp

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-3-(1H-indol-3-yl)propanamido]-4-methylpentanamido]-3-(1H-indol-3-yl)propanoic acid

C31H38N6O5 (574.2903537999999)

Ala Trp Trp Ile

(2S,3S)-2-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-3-(1H-indol-3-yl)propanamido]-3-(1H-indol-3-yl)propanamido]-3-methylpentanoic acid

C31H38N6O5 (574.2903537999999)

Ala Trp Trp Leu

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-3-(1H-indol-3-yl)propanamido]-3-(1H-indol-3-yl)propanamido]-4-methylpentanoic acid

C31H38N6O5 (574.2903537999999)

Asp Glu Arg Arg

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carboxypropanamido]-4-carboxybutanamido]-5-carbamimidamidopentanamido]-5-carbamimidamidopentanoic acid

C21H38N10O9 (574.2823098)

Asp Arg Glu Arg

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carboxypropanamido]-5-carbamimidamidopentanamido]-4-carboxybutanamido]-5-carbamimidamidopentanoic acid

C21H38N10O9 (574.2823098)

Asp Arg Arg Glu

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carboxypropanamido]-5-carbamimidamidopentanamido]-5-carbamimidamidopentanamido]pentanedioic acid

C21H38N10O9 (574.2823098)

Asp Arg Val Trp

(3S)-3-amino-3-{[(1S)-4-carbamimidamido-1-{[(1S)-1-{[(1S)-1-carboxy-2-(1H-indol-3-yl)ethyl]carbamoyl}-2-methylpropyl]carbamoyl}butyl]carbamoyl}propanoic acid

C26H38N8O7 (574.2863318)

Asp Arg Trp Val

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carboxypropanamido]-5-carbamimidamidopentanamido]-3-(1H-indol-3-yl)propanamido]-3-methylbutanoic acid

C26H38N8O7 (574.2863318)

Asp Val Arg Trp

(3S)-3-amino-3-{[(1S)-1-{[(1S)-4-carbamimidamido-1-{[(1S)-1-carboxy-2-(1H-indol-3-yl)ethyl]carbamoyl}butyl]carbamoyl}-2-methylpropyl]carbamoyl}propanoic acid

C26H38N8O7 (574.2863318)

Asp Val Trp Arg

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carboxypropanamido]-3-methylbutanamido]-3-(1H-indol-3-yl)propanamido]-5-carbamimidamidopentanoic acid

C26H38N8O7 (574.2863318)

Asp Trp Arg Val

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carboxypropanamido]-3-(1H-indol-3-yl)propanamido]-5-carbamimidamidopentanamido]-3-methylbutanoic acid

C26H38N8O7 (574.2863318)

Asp Trp Val Arg

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carboxypropanamido]-3-(1H-indol-3-yl)propanamido]-3-methylbutanamido]-5-carbamimidamidopentanoic acid

C26H38N8O7 (574.2863318)

Glu Ile Lys Trp

(4S)-4-amino-4-{[(1S,2S)-1-{[(1S)-5-amino-1-{[(1S)-1-carboxy-2-(1H-indol-3-yl)ethyl]carbamoyl}pentyl]carbamoyl}-2-methylbutyl]carbamoyl}butanoic acid

C28H42N6O7 (574.3114822)

Glu Ile Gln Trp

(4S)-4-amino-4-{[(1S,2S)-1-{[(1S)-3-carbamoyl-1-{[(1S)-1-carboxy-2-(1H-indol-3-yl)ethyl]carbamoyl}propyl]carbamoyl}-2-methylbutyl]carbamoyl}butanoic acid

C27H38N6O8 (574.2750988)

Glu Ile Trp Lys

(2S)-6-amino-2-[(2S)-2-[(2S,3S)-2-[(2S)-2-amino-4-carboxybutanamido]-3-methylpentanamido]-3-(1H-indol-3-yl)propanamido]hexanoic acid

C28H42N6O7 (574.3114822)

Glu Ile Trp Gln

(2S)-2-[(2S)-2-[(2S,3S)-2-[(2S)-2-amino-4-carboxybutanamido]-3-methylpentanamido]-3-(1H-indol-3-yl)propanamido]-4-carbamoylbutanoic acid

C27H38N6O8 (574.2750988)

Glu Lys Ile Trp

(4S)-4-amino-4-{[(1S)-5-amino-1-{[(1S,2S)-1-{[(1S)-1-carboxy-2-(1H-indol-3-yl)ethyl]carbamoyl}-2-methylbutyl]carbamoyl}pentyl]carbamoyl}butanoic acid

C28H42N6O7 (574.3114822)

Glu Lys Leu Trp

(4S)-4-amino-4-{[(1S)-5-amino-1-{[(1S)-1-{[(1S)-1-carboxy-2-(1H-indol-3-yl)ethyl]carbamoyl}-3-methylbutyl]carbamoyl}pentyl]carbamoyl}butanoic acid

C28H42N6O7 (574.3114822)

Glu Lys Trp Ile

(2S,3S)-2-[(2S)-2-[(2S)-6-amino-2-[(2S)-2-amino-4-carboxybutanamido]hexanamido]-3-(1H-indol-3-yl)propanamido]-3-methylpentanoic acid

C28H42N6O7 (574.3114822)

Glu Lys Trp Leu

(2S)-2-[(2S)-2-[(2S)-6-amino-2-[(2S)-2-amino-4-carboxybutanamido]hexanamido]-3-(1H-indol-3-yl)propanamido]-4-methylpentanoic acid

C28H42N6O7 (574.3114822)

Glu Leu Lys Trp

(4S)-4-amino-4-{[(1S)-1-{[(1S)-5-amino-1-{[(1S)-1-carboxy-2-(1H-indol-3-yl)ethyl]carbamoyl}pentyl]carbamoyl}-3-methylbutyl]carbamoyl}butanoic acid

C28H42N6O7 (574.3114822)

Glu Leu Gln Trp

(4S)-4-amino-4-{[(1S)-1-{[(1S)-3-carbamoyl-1-{[(1S)-1-carboxy-2-(1H-indol-3-yl)ethyl]carbamoyl}propyl]carbamoyl}-3-methylbutyl]carbamoyl}butanoic acid

C27H38N6O8 (574.2750988)

Glu Leu Trp Lys

(2S)-6-amino-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-carboxybutanamido]-4-methylpentanamido]-3-(1H-indol-3-yl)propanamido]hexanoic acid

C28H42N6O7 (574.3114822)

Glu Leu Trp Gln

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-carboxybutanamido]-4-methylpentanamido]-3-(1H-indol-3-yl)propanamido]-4-carbamoylbutanoic acid

C27H38N6O8 (574.2750988)

Glu Gln Ile Trp

(4S)-4-amino-4-{[(1S)-3-carbamoyl-1-{[(1S,2S)-1-{[(1S)-1-carboxy-2-(1H-indol-3-yl)ethyl]carbamoyl}-2-methylbutyl]carbamoyl}propyl]carbamoyl}butanoic acid

C27H38N6O8 (574.2750988)

Glu Gln Leu Trp

(4S)-4-amino-4-{[(1S)-3-carbamoyl-1-{[(1S)-1-{[(1S)-1-carboxy-2-(1H-indol-3-yl)ethyl]carbamoyl}-3-methylbutyl]carbamoyl}propyl]carbamoyl}butanoic acid

C27H38N6O8 (574.2750988)

Glu Gln Trp Ile

(2S,3S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-carboxybutanamido]-4-carbamoylbutanamido]-3-(1H-indol-3-yl)propanamido]-3-methylpentanoic acid

C27H38N6O8 (574.2750988)

Glu Gln Trp Leu

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-carboxybutanamido]-4-carbamoylbutanamido]-3-(1H-indol-3-yl)propanamido]-4-methylpentanoic acid

C27H38N6O8 (574.2750988)

Glu Arg Asp Arg

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-carboxybutanamido]-5-carbamimidamidopentanamido]-3-carboxypropanamido]-5-carbamimidamidopentanoic acid

C21H38N10O9 (574.2823098)

Glu Arg Arg Asp

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-carboxybutanamido]-5-carbamimidamidopentanamido]-5-carbamimidamidopentanamido]butanedioic acid

C21H38N10O9 (574.2823098)

Glu Trp Ile Lys

(2S)-6-amino-2-[(2S,3S)-2-[(2S)-2-[(2S)-2-amino-4-carboxybutanamido]-3-(1H-indol-3-yl)propanamido]-3-methylpentanamido]hexanoic acid

C28H42N6O7 (574.3114822)

Glu Trp Ile Gln

(2S)-2-[(2S,3S)-2-[(2S)-2-[(2S)-2-amino-4-carboxybutanamido]-3-(1H-indol-3-yl)propanamido]-3-methylpentanamido]-4-carbamoylbutanoic acid

C27H38N6O8 (574.2750988)

Glu Trp Lys Ile

(2S,3S)-2-[(2S)-6-amino-2-[(2S)-2-[(2S)-2-amino-4-carboxybutanamido]-3-(1H-indol-3-yl)propanamido]hexanamido]-3-methylpentanoic acid

C28H42N6O7 (574.3114822)

Glu Trp Lys Leu

(2S)-2-[(2S)-6-amino-2-[(2S)-2-[(2S)-2-amino-4-carboxybutanamido]-3-(1H-indol-3-yl)propanamido]hexanamido]-4-methylpentanoic acid

C28H42N6O7 (574.3114822)

Glu Trp Leu Lys

(2S)-6-amino-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-carboxybutanamido]-3-(1H-indol-3-yl)propanamido]-4-methylpentanamido]hexanoic acid

C28H42N6O7 (574.3114822)

Glu Trp Leu Gln

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-carboxybutanamido]-3-(1H-indol-3-yl)propanamido]-4-methylpentanamido]-4-carbamoylbutanoic acid

C27H38N6O8 (574.2750988)

Glu Trp Gln Ile

(2S,3S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-carboxybutanamido]-3-(1H-indol-3-yl)propanamido]-4-carbamoylbutanamido]-3-methylpentanoic acid

C27H38N6O8 (574.2750988)

Glu Trp Gln Leu

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-carboxybutanamido]-3-(1H-indol-3-yl)propanamido]-4-carbamoylbutanamido]-4-methylpentanoic acid

C27H38N6O8 (574.2750988)

Phe Phe Val Tyr

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-3-phenylpropanamido]-3-methylbutanamido]-3-(4-hydroxyphenyl)propanoic acid

C32H38N4O6 (574.2791208)

Phe Phe Tyr Val

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-3-phenylpropanamido]-3-(4-hydroxyphenyl)propanamido]-3-methylbutanoic acid

C32H38N4O6 (574.2791208)

Phe Pro Arg Arg

(2S)-2-[(2S)-2-{[(2S)-1-[(2S)-2-amino-3-phenylpropanoyl]pyrrolidin-2-yl]formamido}-5-carbamimidamidopentanamido]-5-carbamimidamidopentanoic acid

C26H42N10O5 (574.3339482)

Phe Arg Pro Arg

(2S)-2-{[(2S)-1-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-5-carbamimidamidopentanoyl]pyrrolidin-2-yl]formamido}-5-carbamimidamidopentanoic acid

C26H42N10O5 (574.3339482)

Phe Arg Arg Pro

(2S)-1-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-5-carbamimidamidopentanamido]-5-carbamimidamidopentanoyl]pyrrolidine-2-carboxylic acid

C26H42N10O5 (574.3339482)

Phe Val Phe Tyr

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-3-methylbutanamido]-3-phenylpropanamido]-3-(4-hydroxyphenyl)propanoic acid

C32H38N4O6 (574.2791208)

Phe Val Tyr Phe

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-3-methylbutanamido]-3-(4-hydroxyphenyl)propanamido]-3-phenylpropanoic acid

C32H38N4O6 (574.2791208)

Phe Tyr Phe Val

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-3-(4-hydroxyphenyl)propanamido]-3-phenylpropanamido]-3-methylbutanoic acid

C32H38N4O6 (574.2791208)

Phe Tyr Val Phe

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-3-(4-hydroxyphenyl)propanamido]-3-methylbutanamido]-3-phenylpropanoic acid

C32H38N4O6 (574.2791208)

His Lys Lys Tyr

(2S)-2-[(2S)-6-amino-2-[(2S)-6-amino-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]hexanamido]hexanamido]-3-(4-hydroxyphenyl)propanoic acid